Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hummel

Showing results (311-320 of 385) with videos related to

Pageof 39
Sort By:
The Journal of Clinical Investigation|June 29, 2018
High-accuracy determination of internal circadian time from a single blood sampleNicole Wittenbrink, Bharath Ananthasubramaniam, Mirjam Münch, et al.
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Oncotarget|December 13, 2017
Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancerSanaz Taromi, Florentine Lewens, Ruza Arsenic, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
The Journal of Molecular Diagnostics : JMD|July 19, 2023
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART AlgorithmMichiel van den Brand, Markus Möbs, Franziska Otto, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Journal of Clinical Pathology|October 5, 2006
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of CancerChalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2021
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencingPhilipp Jurmeister, Claudia Vollbrecht, Korinna Jöhrens, et al.
European Journal of Oral Sciences|August 19, 2015
Genetic influences on dental enamel that impact caries differ between the primary and permanent dentitionsMerve Bayram, Kathleen Deeley, Maria F Reis, et al.
Blood|October 14, 2016
Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphomaJing Du, Martin Neuenschwander, Yong Yu, et al.
Pageof 39

Showing results (311-320 of 385) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Investigation|June 29, 2018
High-accuracy determination of internal circadian time from a single blood sampleNicole Wittenbrink, Bharath Ananthasubramaniam, Mirjam Münch, et al.
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Oncotarget|December 13, 2017
Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancerSanaz Taromi, Florentine Lewens, Ruza Arsenic, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
The Journal of Molecular Diagnostics : JMD|July 19, 2023
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART AlgorithmMichiel van den Brand, Markus Möbs, Franziska Otto, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Journal of Clinical Pathology|October 5, 2006
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of CancerChalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2021
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencingPhilipp Jurmeister, Claudia Vollbrecht, Korinna Jöhrens, et al.
European Journal of Oral Sciences|August 19, 2015
Genetic influences on dental enamel that impact caries differ between the primary and permanent dentitionsMerve Bayram, Kathleen Deeley, Maria F Reis, et al.
Blood|October 14, 2016
Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphomaJing Du, Martin Neuenschwander, Yong Yu, et al.
Pageof 39